Their success highlights a pathway toward faster, cheaper drug development for some genetic illnesses, as well as the ability to pre-test a therapy's safety and effectiveness on cultured clones of a patient's own cells.
http://www.sciencedaily.com/releases/2012/11/121126151021.htm
http://www.sciencedaily.com/releases/2012/11/121126151021.htm
No comments:
Post a Comment